Avenue Therapeutics, Inc. (ATXI)

NASDAQ: ATXI · IEX Real-Time Price · USD

3.450

+0.040 (1.17%)

At close: Jul 19, 2024, 4:00 PM

3.390

-0.060 (-1.74%)

Pre-market: Jul 20, 2024, 9:27 AM EDT

Avenue Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Selling, General & Admin	4.51	4.18	5.35	2.48	2.35	3.07	Upgrade
Research & Development	7.31	10.36	2.7	1.25	2.87	23.19	Upgrade
Operating Expenses	11.82	14.54	8.04	3.74	5.21	26.27	Upgrade
Operating Income	-11.82	-14.54	-8.04	-3.74	-5.21	-26.27	Upgrade
Other Expense / Income	-4.64	-4.16	-4.49	-0.01	-0.06	-0.36	Upgrade
Pretax Income	-7.18	-10.38	-3.55	-3.73	-5.15	-25.91	Upgrade
Net Income	-7.18	-10.38	-3.55	-3.73	-5.15	-25.91	Upgrade
Shares Outstanding (Basic)	1	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	0	0	0	0	0	Upgrade
Shares Change	657.47%	384.72%	92.83%	2.97%	4.99%	53.54%	Upgrade
EPS (Basic)	-7.90	-73.50	-122.25	-246.75	-348.73	-1856.16	Upgrade
EPS (Diluted)	-7.90	-73.50	-122.25	-246.75	-348.73	-1856.16	Upgrade
Free Cash Flow	-11	-9.45	-7.6	-3.75	-5.61	-26.26	Upgrade
Free Cash Flow Per Share	-19.57	-66.92	-260.71	-248.20	-382.54	-1878.93	Upgrade
EBITDA	-7.18	-10.38	-3.55	-3.73	-5.15	-25.91	Upgrade
EBIT	-7.18	-10.38	-3.55	-3.73	-5.15	-25.91	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).